You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -5.4 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | 3.7 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 21.1% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-03-31 | n/a | -3.22 | -6.29p | -3.1 | 0.0 | n/a | n/a | 0.0% |
| 2017-03-31 | n/a | -3.64 | -4.19p | -5.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-03-31 | n/a | -3.03 | -3.28p | -4.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-03-31 | n/a | -3.12 | -2.74p | -7.1 | 0.0 | n/a | n/a | 0.0% |
| 2020-03-31 | n/a | -3.17 | -2.10p | -1.7 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2021-03-31 | 0.00 | -3.80 | -2.30p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2022-03-31 | 0.00 | -1.60 | -1.10p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Evgen Pharma licences technology to Juvenescence Sharecast News | 15 Sep |
|---|---|
| Evgen's 'SFX-01' to be tested with Covid-19 patients Sharecast News | 17 Jun |
| Losses widen as Evgen Pharma develops SFX-01 Sharecast News | 15 Jun |
| Licence agreement with Juvenescence | 15-Sep-20 07:07 |
|---|---|
| Holding(s) in Company | 18-Aug-20 15:31 |
| Holding(s) in Company | 18-Aug-20 15:25 |
| Second Price Monitoring Extn | 14-Aug-20 16:42 |
| Price Monitoring Extension | 14-Aug-20 16:37 |